{
    "clinical_study": {
        "@rank": "36753", 
        "acronym": "S-Pantoprazole", 
        "arm_group": [
            {
                "arm_group_label": "AGSPT_L20", 
                "arm_group_type": "Experimental", 
                "description": "tablet, q.d."
            }, 
            {
                "arm_group_label": "Pantoloc 40mg", 
                "arm_group_type": "Active Comparator", 
                "description": "tablet, q.d."
            }
        ], 
        "brief_summary": {
            "textblock": "Primary object : Evaluate pharmacokinetic property administered S-pantoprazole 20mg and\n      Pantoprazole 40mg in healthy male subjects\n\n      Secondary object : Evaluate safety administered S-pantoprazole 20mg and Pantoprazole 40mg in\n      healthy male subjects"
        }, 
        "brief_title": "Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects", 
        "condition": "Healthy Male Subjects", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult healthy males 20 to 45 years at screening.\n\n          -  BMI : 19kg/m2 ~ 26kg/m2\n\n          -  Blood Pressure : \"140 > sitting SBP \u2265 90mmHg, 90 > sitting DBP \u2265 60mmHg\"\n\n        Exclusion Criteria:\n\n          -  Have history of significant hepatic, renal, gastrointestinal, pulmonary,\n             musculoskeletal, endocrine, neuropsychiatric, hematologic, cardiovascular diseases\n\n          -  Have a gastrointestinal disease(ex : Crohn's disease, gastrointestinal ulcer)or\n             surgery(except for Appendectomy, Hernia repair) affected the absorption of\n             medications\n\n          -  Have history of GERD, Gastric ulcer, Duodenal ulcer\n\n          -  Hypersensitivity reactions to drugs or clinically significant hypersensitivity\n             reactions in the history of benzimidazole(ex:pantoprazole, NSAID, antibiotic)\n\n          -  Have a history of drug abuse\n\n          -  Unusual diet affected the absorption, distribution, metabolism, excretion of\n             medications\n\n          -  Subject who treated with any investigational drugs within 90 days before the\n             administration of investigational drug\n\n          -  Subject who takes inhibitors and inducers of drug metabolizing enzyme (Barbiturates\n             etc.) within 30days\n\n          -  Previously donate whole blood within 60 days or component blood within 30 days or\n             transfusion within 30 days\n\n          -  Subject who have taken habitually caffeine (caffeine > 5 units/day)\n\n          -  Subject who have drunken habitually (alcohol > 21 units/week, 1 unit = pure alcohol\n             10ml)or who are unable to quit drinking during this study or smoker\n\n          -  Subjects deemed ineligible by investigator based on other reasons"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01821521", 
            "org_study_id": "AGSPT_L20PK"
        }, 
        "intervention": [
            {
                "arm_group_label": "AGSPT_L20", 
                "intervention_name": "AGSPT_L20", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Pantoloc 40mg", 
                "intervention_name": "Pantoloc 40mg", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Pantoprazole"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 29, 2013", 
        "location": {
            "contact": {
                "last_name": "Cheul-Hun Seong", 
                "phone": "+82-2-3289-4284"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Asan Medical Center"
            }, 
            "investigator": {
                "last_name": "Kyun-Seop Bae, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Open Label, Single-dose, 2x2 Crossover Study to Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects", 
        "overall_contact": {
            "email": "agcntechpp@ahn-gook.com", 
            "last_name": "Sang-Young Yoon", 
            "phone": "+82-2-3289-4257"
        }, 
        "overall_contact_backup": {
            "email": "agcntechpp@ahn-gook.com", 
            "last_name": "Cheul-Hun Seong", 
            "phone": "+82-2-3289-4284"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Cmax", 
                "safety_issue": "No", 
                "time_frame": "0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24 hours"
            }, 
            {
                "measure": "AUClast", 
                "safety_issue": "No", 
                "time_frame": "0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01821521"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "AUCinf", 
                "safety_issue": "No", 
                "time_frame": "0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24 hours"
            }, 
            {
                "measure": "Tmax", 
                "safety_issue": "No", 
                "time_frame": "0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24 hours"
            }, 
            {
                "measure": "T1/2\u03b2", 
                "safety_issue": "No", 
                "time_frame": "0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24 hours"
            }
        ], 
        "source": "Ahn-Gook Pharmaceuticals Co.,Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ahn-Gook Pharmaceuticals Co.,Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}